Carecubes develops the Carecube ISTARI, an FDA 510(k)-cleared isolation unit built for rapid deployment to enable safe bedside care while isolating pathogens. The product was developed in partnership with infectious disease experts at the University of Nebraska Medical Center and initially funded by DARPA with further support from the CDC and ASPR. Carecubes reports commercial traction, with purchases by hospitals, clinics, and emergency response systems in over 36 communities across 13 states and territories and named customers including Bellevue Hospital of NYC Health+Hospitals and Providence Sacred Heart Medical Center. The company manufactures the units in Minnesota and works with suppliers and partners across multiple U.S. states. Leadership includes CEO Alex Laskey and co-founder Saul Griffith, and the organization has assembled a board and advisors with deep healthcare operations experience. The company announced a $6.5 million Series A in March 2026 to advance its deployment and scale, though the release did not disclose specific revenue figures or a valuation.

Total raised

$7M

Funding rounds

1

Latest round

Series A

Latest activity

Mar 2026